Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.26B |
| 2 |
Microsoft
MSFT
|
+$633M |
| 3 |
Alibaba
BABA
|
+$501M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$484M |
| 5 |
Apple
AAPL
|
+$456M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$622M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$597M |
| 3 |
Comcast
CMCSA
|
+$461M |
| 4 |
UnitedHealth
UNH
|
+$409M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$343M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.03% |
| 2 | Consumer Discretionary | 2.25% |
| 3 | Healthcare | 2.2% |
| 4 | Financials | 2.18% |
| 5 | Industrials | 1.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HYACU
5276
DELISTED
Haymaker Acquisition Corp. III Unit
HYACU
| $2.98M | ﹤0.01% |
300,710
-115,098
| -28% | -$1.14M |
|
5277
Blend Labs
BLND
$482M
| $2.98M | ﹤0.01% |
+220,669
| New | +$3.75M |
|
5278
CALL
Invesco DB Commodity Index Tracking Fund
DBC
$1.63B
| $2.97M | ﹤0.01% |
147,300
-177,600
| -55% | -$3.41M |
|
5279
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.67B
| $2.97M | ﹤0.01% |
30,198
-8,346
| -22% | -$840K |
|
5280
Vident US Bond Strategy ETF
VBND
$526M
| $2.97M | ﹤0.01% |
57,828
-75,659
| -57% | -$3.92M |
|
|
IGMS
5281
CALL
DELISTED
IGM Biosciences
IGMS
| $2.97M | ﹤0.01% |
45,200
+35,100
| +348% | +$2.69M |
|
5282
PUT
Clean Harbors
CLH
$16.4B
| $2.97M | ﹤0.01% |
28,600
+19,600
| +218% | +$1.93M |
|
|
LITS
5283
Lite Strategy Inc
LITS
$32.1M
| $2.97M | ﹤0.01% |
53,829
-29,942
| -36% | -$1.65M |
|
5284
CALL
Sanofi
SNY
$102B
| $2.97M | ﹤0.01% |
61,600
+17,700
| +40% | +$900K |
|
5285
PUT
Takeda Pharmaceutical
TAK
$52.9B
| $2.97M | ﹤0.01% |
181,300
-2,900
| -2% | -$48.7K |
|
5286
Integer Holdings
ITGR
$4.25B
| $2.97M | ﹤0.01% |
+33,224
| New | +$3.11M |
|
|
EH
5287
PUT
EHang Holdings
EH
$417M
| $2.97M | ﹤0.01% |
124,100
+23,300
| +23% | +$635K |
|
|
MDC
5288
DELISTED
M.D.C. Holdings, Inc.
MDC
| $2.96M | ﹤0.01% |
63,388
-28,436
| -31% | -$1.44M |
|
5289
AEye
LIDR
$58.4M
| $2.96M | ﹤0.01% |
18,038
+14,463
| +405% | +$4M |
|
|
KNBE
5290
CALL
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
| $2.96M | ﹤0.01% |
+134,700
| New | +$3.36M |
|
5291
PUT
Silicon Laboratories
SLAB
$7.2B
| $2.96M | ﹤0.01% |
21,100
+11,600
| +122% | +$1.74M |
|
|
ITCI
5292
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.96M | ﹤0.01% |
79,300
+10,700
| +16% | +$372K |
|
|
CIZ
5293
DELISTED
VictoryShares Developed Enhanced Volatility Wtd ETF
CIZ
| $2.95M | ﹤0.01% |
88,899
+19,042
| +27% | +$659K |
|
5294
PUT
Vir Biotechnology
VIR
$1.55B
| $2.95M | ﹤0.01% |
67,800
+12,900
| +23% | +$558K |
|
5295
Standex International
SXI
$3.91B
| $2.95M | ﹤0.01% |
29,821
+26,205
| +725% | +$2.49M |
|
|
CAN
5296
CALL
Canaan Creative
CAN
$149M
| $2.95M | ﹤0.01% |
482,100
+87,600
| +22% | +$681K |
|
5297
CALL
Revvity
RVTY
$12.4B
| $2.95M | ﹤0.01% |
17,000
-20,200
| -54% | -$3.56M |
|
5298
Assembly Biosciences
ASMB
$524M
| $2.94M | ﹤0.01% |
70,527
+2,803
| +4% | +$117K |
|
5299
Edgewell Personal Care
EPC
$1.31B
| $2.94M | ﹤0.01% |
81,132
+36,754
| +83% | +$1.51M |
|
|
VLTA
5300
CALL
DELISTED
Volta Inc.
VLTA
| $2.94M | ﹤0.01% |
340,300
+113,900
| +50% | +$1.17M |
|
Similar funds
Citadel Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Citadel Advisors held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Citadel Advisors deployed $38.1B of net new capital in Q3 2021, opening 1,884 new positions and adding to 5,796 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.
- Citadel Advisors's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
- Citadel Advisors added most to Tesla in Q3 2021, an estimated $1.26B increase.
- Citadel Advisors's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
- Citadel Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
- Citadel Advisors's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
- Citadel Advisors opened 1,884 new positions and closed 1,724 in Q3 2021.
- Citadel Advisors's portfolio value rose 7.8% quarter-over-quarter to $481B.
Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.